M. C. Solcia

A Nanostructured Lipid System to Improve the Oral Bioavailability of Ruthenium(II) Complexes for the Treatment of Infections Caused by Mycobacterium tuberculosis

M. Chorilli, F. Pavan, P. D. da Silva, 2018, Front. Microbiol..

Furoxan derivatives demonstrated in vivo efficacy by reducing Mycobacterium tuberculosis to undetectable levels in a mouse model of infection.

S. Franzblau, M. Chorilli, F. Pavan, 2020, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

Design, Synthesis, and Characterization of N-Oxide-Containing Heterocycles with in Vivo Sterilizing Antitubercular Activity

L. Lazzarato, R. Fruttero, L. D. de Carvalho, 2017, Journal of medicinal chemistry.

Exploiting the furo[2,3-b]pyridine core against multidrug-resistant Mycobacterium tuberculosis.

F. Pavan, Flavio da Silva Emery, M. C. Solcia, 2019, Bioorganic & medicinal chemistry letters.

Cytotoxic and apoptotic effects of ternary silver(i) complexes bearing 2-formylpyridine thiosemicarbazones and 1,10-phenanthroline.

M. Cominetti, F. Pavan, J. Pereira, 2020, Dalton transactions.

Growth-inhibitory effects of tris-(1,10-phenanthroline) iron (II) against Mycobacterium tuberculosis in vitro and in vivo.

F. Pavan, D. L. Campos, Patrícia Bento da Silva, 2021, Tuberculosis.

Latent Tuberculosis: A Promising New Compound to Treat Non-Replicating and Intramacrophagic Mycobacteria

F. Pavan, P. C. de Souza, D. L. Campos, 2022, Biomedicines.